VANGL1 and glioblastoma: In our co-immunoprecipitation and mass spectrometry analysis for SFRP2-interactors we instead detected other non-canonical WNT-signaling components including VANGL1, a transmembrane protein associated with non-canonical WNT-signaling recently reported to alter cell motility in glioblastoma [40].